Moderna, Merck Drugs Combined Shown Effective Against Melanoma
Voice of America
FILE - People pose with a syringe in front of a Moderna logo. Moderna, along with fellow pharmaceutical company Merck, announced Dec. 14, 2023, they had found success in reducing the chance of recurrence of melanoma by combining a Moderna vaccine with Merck's Keytruda.
U.S. pharmaceutical companies Moderna and Merck say a clinical trial for an experimental Moderna mRNA vaccine used in combination with the Merck cancer therapy drug Keytruda reduced the chance of recurrence or death from melanoma by nearly 50%.
More Related News